Discover they major updates in oncology from the 2024 ESMO Congress, including featured breakthroughs from the leading ...

Some patients with advanced kidney cancers were good candidates for powerful immunotherapy cancer medicines, but George's ...

Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on IO Biotech (IOBT – Research Report). The associated price ...

Wells Fargo analyst Derek Archila maintained a Hold rating on Sutro Biopharma (STRO – Research Report) yesterday and set a price target ...

At the ESMO Congress 2024, ICON shared survey findings highlighting concerns among oncology professionals about the impact of ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation ... at 07:26 Medivir to present mature clinical data for fostrox + Lenvima at ESMO Conference and to host a webcast on September ...

MindgruveMacarta, a global performance marketing, retail media and data-tech company, today announced its merger with Icon Commerce, the largest independent commerce agency in the Midwest. This ...

Harnessing the power of the immune system has emerged as a key approach in addressing T-cell malignancies, with efforts to leverage the immune system leading to significant improvements beyond the ...

Details on the ESMO posters are below. Posters will be available on the 23andMe Therapeutics and Investor websites following the presentations.

As of the writing, there is no official statement from Facebook regarding the reason for changing the icon to black and blue. However, it may be related to the upcoming full release of iOS 18 on ...